FDA warning letter · Drugs

New Vitalis, LLC dba New Vitalis Pharmacy

Issued · Posted by FDA

Selected passages from the FDA letter

Quoted FDA text from the published dataset. These selected excerpts are not the complete letter.

Passage 1

Vermin were observed in an area immediately adjacent to the firm’s production area.

Passage 2

Production areas were difficult to clean or contain porous, particle generating, or visibly dirty surfaces. Specifically, debris on the floor, peeling (b)(4) tape with an apparent build-up of black residue on the floor in the ISO 7 cleanroom, and black residue build-up around (b)(4) HEPA filters were observed.

Passage 3

An operator blocked first air by placing gloved hands directly over open sterile containers.

Passage 4

HEPA filters were not sealed around each perimeter to the support frame.

Passage 5

Personnel failed to disinfect gloves and components to prevent contamination.

Passage 6

Personnel donned gowning apparel improperly in a way that may have caused the gowning apparel to become contaminated.

Passage 7

Your firm handled hazardous drug products without providing adequate cleaning of utensils to prevent cross-contamination.